Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
Elizabeth M. Holland(University of Maryland, Baltimore), Nirali N. Shah(National Institutes of Health), Constance M. Yuan(National Cancer Institute), Daniel A. Lichtenstein(National Institutes of Health), John A. Ligon(University of Florida Health), Bonnie Yates(National Institutes of Health), Maryalice Stetler‐Stevenson(National Cancer Institute), Haneen Shalabi(Center for Cancer Research), Daniel W. Lee(University of Virginia Cancer Center), Michael LaLoggia(National Institutes of Health), Mark A. Ahlman(Augusta University), John C. Molina, Hao‐Wei Wang(Fu Jen Catholic University), Alexander Ling(Centre for Quantum Technologies)
Cited by 67
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744